201 studies found for:    Open Studies | "Tuberculosis"
Show Display Options
Rank Status Study
21 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
22 Recruiting A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Interventions: Drug: Bedaquiline;   Drug: PA-824;   Drug: Linezolid
23 Unknown  A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis
Condition: Tuberculosis
Intervention: Drug: Gatifloxacin combined regimen
24 Unknown  Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis
Condition: Tuberculosis
Intervention: Drug: combined fixed dose combination
25 Unknown  Latency in Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Drug: Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol
26 Not yet recruiting Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults
Condition: Latent Tuberculosis
Intervention: Procedure: Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)
27 Unknown  Pharmacokinetic Study for Anti-tuberculosis Drugs
Condition: Pulmonary Tuberculosis
Intervention: Drug: Rifater and EMB
28 Unknown  The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
Conditions: Rheumatic Disease;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Tuberculosis
29 Recruiting Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis
Condition: Tuberculosis Infection
30 Recruiting Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Interventions: Drug: Isoniazid with HUEXC030 and RZE;   Drug: HRZE
31 Unknown  Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
Condition: Tuberculosis
32 Not yet recruiting Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis
Conditions: Type 2 Diabetes Mellitus;   Pulmonary Tuberculosis
Interventions: Dietary Supplement: Vitamin D;   Dietary Supplement: Calcium;   Dietary Supplement: Placebo Vit D;   Dietary Supplement: Placebo Calcium
33 Recruiting Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Procedure: Diagnostic techniques in pulmonary tuberculosis
34 Recruiting Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis
Condition: Tuberculosis
Interventions: Device: Digital Health Feedback System;   Other: SOC DOT
35 Unknown  Spatial Epidemiology of Tuberculosis (TB) Infection
Condition: Tuberculosis
36 Recruiting Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
Condition: Tuberculosis
Interventions: Other: PCR-based strategy;   Drug: isoniazid (INH or H);   Drug: rifampicin (RIFor RMP or R);   Drug: pyrazinamide (PZA or Z);   Drug: ethambutol (EMB or E)
37 Recruiting Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis
Condition: Pulmonary Tuberculosis Without Resistance to Rifampicin
Interventions: Drug: Linezolid;   Drug: Ethambutol
38 Unknown  Diagnosis of Active Tuberculosis by ELISPOT
Condition: Tuberculosis
39 Recruiting Shortening Treatment by Advancing Novel Drugs
Conditions: Tuberculosis, Pulmonary, Drug Sensitive;   Tuberculosis, Pulmonary, Multi Drug-resistant
Interventions: Drug: Moxifloxacin;   Drug: PA-824;   Drug: Pyrazinamide;   Drug: HRZE (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol combination tablet);   Drug: HR (rifampicin plus isoniazid combination tablets)
40 Unknown  Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs
Condition: Tuberculosis
Interventions: Drug: Silymarin;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years